Please try another search
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Eugene Williams | 64 | 2015 | Co-Founder & Chairman |
Neil R. Cashman | 71 | 2004 | Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director |
Neil K. Warma | 61 | 2021 | President, Interim CEO, Principal Executive Officer & Director |
Patrick D. Kirwin | 67 | 2015 | Independent Director |
Sharon Cohen | - | 2018 | Member of Scientific Advisory Board |
Michael J. Higgins | 62 | - | Member of Business Advisory Board |
William W. Wyman | 86 | 2014 | Independent Director |
Cheryl Wellington | - | 2022 | Member of Scientific Advisory Board |
William C. Mobley | - | 2017 | Member of Scientific Advisory Board |
Timothy G. Rothwell | 73 | 2019 | Member of Business Advisory Board |
Andre Strydom | - | 2019 | Member of Scientific Advisory Board |
Nigel Burns | - | - | Member of Business Advisory Board |
Charles Warren Olanow | - | 2019 | Member of Scientific Advisory Board |
Michelle L. Hastings | - | - | Member of Scientific Advisory Board |
Guy A. Rouleau | - | 2022 | Member of Scientific Advisory Board |
Joshua Mandel-Brehm | 40 | 2021 | Independent Director |
Carsten Korth | - | 2022 | Member of Scientific Advisory Board |
Madge K. Shafmaster | 65 | 2021 | Lead Independent Director |
Alain Dagher | - | 2022 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review